In the framework of the Erasmus+ Mundus Joint Master’s Degree entitled “Leading International Vaccinology Education” (LIVE) three students have completed their internship at NESI in 2018, 2019 and 2020. LIVE is a two years Master’s programme, between five European universities: Université Claude Bernard Lyon 1, France (coordinating university); Universitat Autonoma de Barcelona, Spain; Universitat de Barcelona, Spain; University of Antwerp, Belgium; Université Jean Monnet Saint-Etienne, France. The programme is supported by a worldwide network of 31 international associated partners and 16 supporting partners. NESI is supporting partner to the LIVE programme.
Summary of internship project 2020:
In spite of safe and effective vaccines, measles is still the leading cause of vaccine-preventable deaths among children under 5 years old. To interrupt measles transmission and prevent the disease, immunising more than 90% of the population is vital. However, achieving the targeted coverage of measles vaccination can be dampened by several reasons; among them is vaccine hesitancy. Since 2016, Uganda experienced several measles outbreaks. Even though all the vaccines are provided by the government for free, the national coverage of the first measles vaccine dose in Kampala Area (Including Wakiso District) was only 86% in 2016. Wakiso District was listed as one of the districts suffering recurrent measles outbreaks in 2018. The study aimed to explore the reasons behind the measles outbreaks in Wakiso District, and whether vaccine hesitancy played a role. Additionally, the study evaluated vaccine hesitancy assessing tool developed by WHO SAGE with the tailored questionnaire adjusted to Uganda country settings and measles disease and vaccination.
The study was conducted in collaboration with ECAVI, using two questionnaires during face-to-face interviews with the general population who presented in health facilities for immunising their child. The results of this project pinpointed the attitude shift towards the newly introduced Measles Rubella vaccine in Uganda with coexisting convenience issues that may dampen the vaccine demand in Wakiso District.
The student successfully defended her thesis in Antwerp on 2 July 2020.
Yu-Tan Chen. Assessing confidence in measles vaccination in Wakiso District, Uganda: Comparison of two data collection tools.
Summary of internship project 2019:
Many countries worldwide are embarking on the introduction of new vaccines, including the HPV vaccine. The South-East Asian Region is the one most lagging behind regarding new vaccine introduction and immunisation programme strengthening. This has considerable impact on child morbidity and mortality, as by far the greatest birth cohorts are in this Region. Indonesia has a well-functioning immunisation programme, with 83% spending on routine immunisation financed by the government. However, recently the immunisation coverage is stagnating. Demonstration projects for pneumococcal conjugate vaccine and HPV vaccine are currently being implemented before nation-wide introduction. Rotavirus vaccine has not yet been introduced. As many new vaccines are anticipated to be introduced in the coming years in Indonesia, the study aims to understand the acceptability and potential barriers to vaccination in general and specifically to the HPV vaccine in the general population.
The study used an online self-administered anonymous questionnaire and targeted a sub-population of the general public in Indonesia. The results of this project highlighted which areas need special attention for successful introduction of new vaccines, especially the HPV vaccine.
The student successfully defended his thesis in Barcelona on 13 June 2019.
Madan Khatiwada. To understand the acceptability of vaccines and potential barriers to vaccination in general and specifically to HPV vaccines among university students in Indonesia.
Summary of internship project 2018:
Several countries worldwide are embarking on the introduction of the HPV vaccine into their national immunisation programme. One of the regions lagging behind in the introduction of the HPV vaccine is the Eastern Mediterranean Region. The purpose of this project was to better understand the reasons behind this delay in order to make recommendations to guide countries to successfully introduce the HPV vaccine. Specifically, the project aimed to understand the current knowledge on cervical cancer and HPV vaccine, to identify the acceptability and potential barriers to introduce the HPV vaccine in the region, and to identify optimal delivery and communication strategies with the public. The study used an online self-administered questionnaire targeting university students. The results of this project highlighted areas needing special attention for successful introduction of the HPV vaccine in selected countries in the Eastern Mediterranean Region.
The student successfully defended his thesis in Lyon on 12 June 2018.
Inayat Ur Rehman. Knowledge and awareness about cervical cancer, HPV vaccine, its acceptability and potential barriers in its introduction in the Eastern Mediterranean Region (Morocco and Pakistan).
Last Updated :
Make a donation now
By supporting NESI you are contributing to “Saving lives through immunisation”.